The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Jan. 22, 2019
Filed:
Nov. 22, 2016
Applicant:
Ardea Biosciences, Inc., San Diego, CA (US);
Inventors:
Barry D. Quart, Encinitas, CA (US);
Jean-Luc Girardet, San Diego, CA (US);
Esmir Gunic, San Diego, CA (US);
Li-Tain Yeh, Irvine, CA (US);
Assignee:
Ardea Biosciences, Inc., San Diego, CA (US);
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/4196 (2006.01); C07D 249/12 (2006.01); A61K 31/7068 (2006.01); A61K 31/7072 (2006.01); A61K 31/7076 (2006.01); A61K 45/06 (2006.01); C07D 249/14 (2006.01); C07H 19/06 (2006.01); C07H 19/16 (2006.01); A61K 31/7056 (2006.01); C07H 7/02 (2006.01);
U.S. Cl.
CPC ...
A61K 31/4196 (2013.01); A61K 31/7056 (2013.01); A61K 31/7068 (2013.01); A61K 31/7072 (2013.01); A61K 31/7076 (2013.01); A61K 45/06 (2013.01); C07D 249/12 (2013.01); C07D 249/14 (2013.01); C07H 7/02 (2013.01); C07H 19/06 (2013.01); C07H 19/16 (2013.01);
Abstract
Described herein are compounds useful in the modulation of blood uric acid levels, formulations containing them and methods of using them. In some embodiments, the compounds described herein are used in the treatment or prevention of disorders related to aberrant levels of uric acid.